Posters
| Name | Organization | Job Title/Position | Abstract Title | Abstract Category |
|---|---|---|---|---|
| Ms. Kimberly Wilkins | Centers for Disease Control and Prevention | Research Assistant | Analysis of mpox testing at the CDC during the 2022 multinational mpox outbreak | Viral Genomics & Proteomics |
| Dr Susana Guerra | Autonomous University of Madrid | Principal Investigator | An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses | Viral Vectors & Vaccine Development |
| Preetam Parija | University of Surrey | PhD Student | A role for the E3 ligase FBXO22 in antiviral immunity and its antagonism by orthopoxviruses | Virus-Host Cell Interaction & Signalling |
| Mrs Pia Veratti | University Hospital Freiburg | Research Assistant | Comparative poxvirus transcriptomics | Gene Expression & Genome Replication |
| Dr Stephen Laidlaw | University of Oxford | Postdoctoral Fellow | Development & Assessment of a Lateral Flow Device for Detection of Mpox and Other Orthopoxviruses | Viral Pathogenesis & Therapeutics |
| Mr. Vaughn Wicker | ORAU | ORISE Post-baccalaureate Research Fellow | Development of new real-time PCR assays to improve the detection of Mpox virus (MPXV) variants | Emerging Poxviruses |
| Dr Rafael Blasco | INIA CSIC | Principal Investigator | Dissecting the transcriptome of a replication competent Poxvirus infection at single cell resolution | Virus-Host Cell Interaction & Signalling |
| Dr. Jingxin Cao | National Microbiology Laboratory | Principal Investigator | E3L deletion mutant vaccinia/NYCBH as a platform for recombinant vaccine: expression of the spike and the nucleocapsid proteins protect against SARS-CoV-2 infection in hamsters | Viral Vectors & Vaccine Development |
| Santiago Navarro | Texas A&M University | PhD Student | Evaluation of MVA plaque assay by crystal violet staining in continuous chicken embryo fibroblasts DF-1 | Viral Vectors & Vaccine Development |
| Dr. Nicolle Baird | CDC | Principal Investigator | Evidence of Monkeypox Virus Infection from Non-Lesion Specimens Among Persons Without Characteristic Lesions or Rash - District of Columbia, August 2022 | Emerging Poxviruses |
| Dr Yu Li | CDC | Principal Investigator | Genomic deletions and rearrangements in monkeypox viruses from the 2022 outbreak, USA | Viral Genomics & Proteomics |
| Mr Guillermo Albericio | Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain. | Postdoctoral Fellow | Impact of the COVID-19 vaccine candidate MVA-CoV2-S on lung transcriptomes of K18-hACE2 mice challenged with SARS-CoV-2 | Viral Vectors & Vaccine Development |
| Dr. Alexandria Krueger | University of Nebraska-Lincoln | Postdoctoral Fellow | Inducible expression of an epitope-tagged H5 allows study of phospho-regulation by the B1 kinase and the viral and cellular components comprising vaccinia replication factories | Gene Expression & Genome Replication |
| Mrs Laetitia Montacq | INRAE/ENVT | Research Assistant | Interest of Non-lethal Sampling Methods in Detection and Genotyping of Carp Edema Virus in Koi Carp Trade | Emerging Poxviruses |
| Gracie Ann Fischer | Centers for Disease Control and Prevention | Research Assistant | Investigation of non-lesion skin samples as diagnostic specimen for Orthopoxvirus detection in animals | Emerging Poxviruses |
| Dr Susana Guerra | Autonomous University of Madrid | Principal Investigator | ISG15 Is Required for the Dissemination of Vaccinia Virus Extracellular Virions | Virus-Host Cell Interaction & Signalling |
| Mr. Bruno Hernaez | Centro de Biologia Molecular Severo Ochoa (CBMSO) | Postdoctoral Fellow | Monitoring mpox virus in saliva and air samples | Emerging Poxviruses |
| Dr Chathura Suraweera | Australian National University | Postdoctoral Fellow | Monkeypox virus C7L is a Bcl-2-fold protein that binds human pro-apoptotic Bcl-2 proteins | Virus-Host Cell Interaction & Signalling |
| Luis J. Sigal | Department of Microbiology and Immunology, Thomas Jefferson University. | Principal Investigator | Necroptosis does not seem to play an important role in resistance to poxvirus infection | Viral Pathogenesis & Therapeutics |
| Dr. Zhengqiang (ZQ) Wang | Center for Drug Design, University of Minnesota | Principal Investigator | Novel and Structurally Distinct Antiviral Hits against Orthopoxviruses | Viral Pathogenesis & Therapeutics |
| Name | Organization | Job Title/Position | Abstract Title | Abstract Category |
|---|---|---|---|---|
| Ngadhnjim Latifi | University Hospital Tübingen | Scientist | A novel multi-antigenic parapoxvirus-based vaccine demonstrates efficacy in protecting hamsters and non-human primates against SARS-CoV-2 challenge | Viral Vectors & Vaccine Development |
| Dr. Jingxin Cao | National Microbiology Laboratory | Principal Investigator | Application of VACV E3L and K3L double deletion system to reveal SARS-CoV-2 N as an inhibitor of PKR and OAS/RNase L antiviral pathways | Virus-Host Cell Interaction & Signalling |
| Mr. Michael Townsend | Centers for Disease Control and Prevention | Microbiologist / B.S. | Demonstration of acute phase anti-orthopoxvirus IgM response from clinical sample testing during the 2022 multinational mpox outbreak | Emerging Poxviruses |
| Mr. William Carson | Centers for Disease Control and Prevention | Microbiologist / B.S. | Demonstration of acute phase anti-orthopoxvirus IgM response from clinical sample testing during the 2022 multinational mpox outbreak | Emerging Poxviruses |
| Dr. Sergio Rodriguez | US Centers for Disease Control and Prevention (CDC) | Postdoctoral Fellow | Development of a luciferase-based assay for the detection of mpox neutralizing antibody in human serum | Viral Immunity |
| Mr Juan García-Arriaza | Departamento de Biología Molecular y Celular, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain. | Principal Investigator | Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate | Viral Vectors & Vaccine Development |
| Mr Cihan Inan | Karadeniz Technical University | Principal Investigator | Functional analysis of Amsacta moorei entomopoxvirus entry-fusion complex member AMV217. | Virus Entry |
| Terese Navarra | Centers for Disease Control and Prevention | Microbiologist | Immune response to JYNNEOS vaccination among persons receiving two vaccine doses - District of Columbia, 2022 | Viral Immunity |
| Mrs. Beatriz Perdiguero | Centro Nacional de Biotecnología | Postdoctoral Fellow | Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate | Viral Vectors & Vaccine Development |
| Mrs Carmen Elena Gómez | Centro Nacional de Biotecnología | Principal Investigator | Immunogenicity and protective efficacy of trimeric SARS-CoV-2 S receptor binding domain after heterologous mRNA/MVA regimen | Viral Vectors & Vaccine Development |
| Dr. Prof Rachel Roper | East Carolina University, Brody School of Medicine | Principal Investigator | Improving Safety and Efficacy of Poxvirus Vaccines for Smallpox and Monkeypox by Removal of A35R and O1L Virulence Genes | Viral Vectors & Vaccine Development |
| Dr Susana Guerra | Autonomous University of Madrid | Principal Investigator | ISG15 Is a Novel Regulator of Lipid Metabolism during Vaccinia Virus Infection | Virus-Host Cell Interaction & Signalling |
| Ms. Heather Mercer | University of Birmingham | Postdoctoral Fellow | Modulation of Histone 3 phosphorylation by Vaccinia H1 phosphatase is critical for VACV infection | Virus-Host Cell Interaction & Signalling |
| Mrs Patricia Pérez | Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain. | Postdoctoral Fellow | MVA-based vaccine candidates expressing prefusion-stabilized spike proteins from SARS-CoV-2 Wuhan and beta variant of concern are highly immunogenic and protects mice from a lethal challenge with SARS-CoV-2 beta variant | Viral Vectors & Vaccine Development |
| Mr Joseph Patrick McGrail Gámiz | Autonomous University of Madrid | PhD Student | Phylogenetic and Ultrastructural Analysis of NY MPOX | Emerging Poxviruses |
| Dr P.S. Satheshkumar | Centers for Disease Control and Prevention | Principal Investigator | Retrospective serosurvey to determine anti-orthopoxvirus antibody prevalence | Viral Immunity |
| Mr Juan García-Arriaza | Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain. | Principal Investigator | Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy | Viral Vectors & Vaccine Development |
| Mrs. Clara Feldmann | Leibniz Institut für Virologie | PhD Student | Studying the assembly of Vaccinia virus using cellular electron cryo tomography | Virus Assembly & Trafficking |
| Henri Groger | Institut de biologie structurale | PhD Student | Study of the DNA replication machinery of vaccinia virus by cryo-EM | Gene Expression & Genome Replication |
| Hadas Tamir | IIBR | Researcher | Synergistic effect of human-like monoclonal antibodies in Poxvirus protection | 0 |